The effect of prenatal vaginal progesterone on cervical length in nonselected twin pregnancies

References

• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
   PubMed Web of Science ®Google Scholar
• Csapo AI, Pulkkinen MO, Wiest WG. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol. 1973;115(6):759–765.
   PubMed Web of Science ®Google Scholar
• Romero R. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment. Ultrasound Obstet Gynecol. 2007;30(5):675–686.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Insel PA, Goldfien A. Regulation of myometrial adrenoreceptors and adrenergic response by sex steroids. Mol Pharmacol. 1981;20(1):52–58.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Nakamura T, Ikeya H, et al. Hyaluronate depolymerization activity induced by progesterone in cultured fibroblasts derived from human uterine cervix. FEBS Lett. 1994;347(1):95–98.
   PubMed Web of Science ®Google Scholar
• da Fonseca EB, Bittar RE, Carvalho MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188(2):419–424.
   PubMed Web of Science ®Google Scholar
• Fonseca EB, Celik E, Parra M, et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357(5):462–469.
   PubMed Web of Science ®Google Scholar
• Romero R, Nicolaides K, Conde-Agudelo A, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206(2):124.e1–124.19.
   PubMed Web of Science ®Google Scholar
• Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379–2385.
   PubMed Web of Science ®Google Scholar
• Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18–31.
   PubMed Web of Science ®Google Scholar
• Romero R, Nicolaides KH, Conde-Agudelo A, et al. Vaginal progesterone decreases preterm birth ≤34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol. 2016;48(3):308–317.
   PubMed Web of Science ®Google Scholar
• Rouse DJ, Caritis SN, Peaceman AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;357(5):454–461.
   PubMed Web of Science ®Google Scholar
• Lim AC, Schuit E, Bloemenkamp K, et al. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. Obstet Gynecol. 2011;118(3):513–520.
   PubMed Web of Science ®Google Scholar
• Norman JE, Mackenzie F, Owen P, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 2009;373(9680):2034–2040.
   PubMed Web of Science ®Google Scholar
• Wood S, Ross S, Tang S, et al. Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial. J Perinat Med. 2012;40(6):593–599.
   PubMed Web of Science ®Google Scholar
• Serra V, Perales A, Meseguer J, et al. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. BJOG. 2013;120(1):50–57.
   PubMed Web of Science ®Google Scholar
• Brizot ML, Hernandez W, Liao AW, et al. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2015;213(1):82.e1–82.e9.
   Web of Science ®Google Scholar
• Awwad J, Usta IM, Ghazeeri G, et al. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity. BJOG. 2015;122(1):71–79.
   PubMed Web of Science ®Google Scholar
• Schuit E, Stock S, Rode L, et al. Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG. 2015;122(1):27–37.
   PubMed Web of Science ®Google Scholar
• Romero R, Conde-Agudelo A, El-Refaie W, et al. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol. 2017;49(3):303–314.
   PubMed Web of Science ®Google Scholar
• Heath VC, Southall TR, Souka AP, et al. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 1998;12(5):312–317.
   PubMed Web of Science ®Google Scholar
• Souka AP, Heath V, Flint S, et al. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol. 1999;94(3):450–454.
   PubMed Web of Science ®Google Scholar
• Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996;334(9):567–572.
   PubMed Web of Science ®Google Scholar
• Pessel C, Moni S, Zork N, et al. The effect of intramuscular progesterone on the rate of cervical shortening. Am J Obstet Gynecol. 2013;209(3):269.e1–269.e7.
   Web of Science ®Google Scholar
• Durnwald CP, Lynch CD, Walker H, et al. The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. Am J Obstet Gynecol. 2009;201(4):410.e1–410.e5.
   Web of Science ®Google Scholar
• O’Brien JM, DeFranco EA, Adair CD, et al. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2009;34(6):653–659.
   PubMed Web of Science ®Google Scholar
• Durnwald CP, Momirova V, Rouse DJ, et al. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 2010;23(12):1360–1364.
   PubMed Web of Science ®Google Scholar
• Lim AC, Schuit E, Papatsonis D, et al. Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies. Ultrasound Obstet Gynecol. 2012;40(4):426–430.
   PubMed Web of Science ®Google Scholar
• Sonek JD, Iams JD, Blumenfeld M, et al. Measurement of cervical length in pregnancy: comparison between vaginal ultrasonography and digital examination. Obstet Gynecol. 1990;76(2):172–175.
   PubMed Web of Science ®Google Scholar
• de Oliveira LA, Brizot ML, Liao AW, et al. Prenatal administration of vaginal progesterone and frequency of uterine contractions in asymptomatic twin pregnancies. Acta Obstet Gynecol Scand. 2016;95(4):436–443.
   PubMed Web of Science ®Google Scholar